Cargando…
Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
RA is a chronic, systemic, autoimmune disease characterized by inflammation and degradation of the joints, causing significant negative impact on quality of life. In addition to joint disease, symptoms and co-morbidities associated with RA—namely pain, fatigue and mood disorders—are often as debilit...
Autores principales: | Choy, Ernest H S, Calabrese, Leonard H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199533/ https://www.ncbi.nlm.nih.gov/pubmed/29186541 http://dx.doi.org/10.1093/rheumatology/kex391 |
Ejemplares similares
-
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010) -
Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020) -
Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014) -
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019) -
Fatigue in rheumatoid arthritis
por: Choy, Ernest H, et al.
Publicado: (2019)